248 related articles for article (PubMed ID: 19321177)
1. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.
Thompson M; Weickert CS; Wyatt E; Webster MJ
J Psychiatr Res; 2009 Jul; 43(11):970-7. PubMed ID: 19321177
[TBL] [Abstract][Full Text] [Related]
2. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
Woo TU; Walsh JP; Benes FM
Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.
Bielau H; Steiner J; Mawrin C; Trübner K; Brisch R; Meyer-Lotz G; Brodhun M; Dobrowolny H; Baumann B; Gos T; Bernstein HG; Bogerts B
Ann N Y Acad Sci; 2007 Jan; 1096():157-69. PubMed ID: 17405927
[TBL] [Abstract][Full Text] [Related]
4. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia.
Dracheva S; Elhakem SL; McGurk SR; Davis KL; Haroutunian V
J Neurosci Res; 2004 May; 76(4):581-92. PubMed ID: 15114630
[TBL] [Abstract][Full Text] [Related]
5. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
6. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
Uezato A; Meador-Woodruff JH; McCullumsmith RE
Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
[TBL] [Abstract][Full Text] [Related]
7. Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil.
Gos T; Günther K; Bielau H; Dobrowolny H; Mawrin C; Trübner K; Brisch R; Steiner J; Bernstein HG; Jankowski Z; Bogerts B
J Affect Disord; 2009 Feb; 113(1-2):45-55. PubMed ID: 18538859
[TBL] [Abstract][Full Text] [Related]
8. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
[TBL] [Abstract][Full Text] [Related]
9. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.
Webster MJ; Knable MB; O'Grady J; Orthmann J; Weickert CS
Mol Psychiatry; 2002; 7(9):985-94, 924. PubMed ID: 12399952
[TBL] [Abstract][Full Text] [Related]
10. Glutamic acid decarboxylase 65, 67, and GABA-transaminase mRNA expression and total enzyme activity in the goldfish (Carassius auratus) brain.
Martyniuk CJ; Awad R; Hurley R; Finger TE; Trudeau VL
Brain Res; 2007 May; 1147():154-66. PubMed ID: 17362888
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders.
Akbarian S; Huang HS
Brain Res Rev; 2006 Sep; 52(2):293-304. PubMed ID: 16759710
[TBL] [Abstract][Full Text] [Related]
12. Caloric restriction augments brain glutamic acid decarboxylase-65 and -67 expression.
Cheng CM; Hicks K; Wang J; Eagles DA; Bondy CA
J Neurosci Res; 2004 Jul; 77(2):270-6. PubMed ID: 15211593
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
14. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.
Heckers S; Stone D; Walsh J; Shick J; Koul P; Benes FM
Arch Gen Psychiatry; 2002 Jun; 59(6):521-9. PubMed ID: 12044194
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
Carletti R; Corsi M; Melotto S; Caberlotto L
Eur J Neurosci; 2005 Mar; 21(6):1712-8. PubMed ID: 15845098
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of glyoxalase-1 mRNA in mood disorder patients.
Fujimoto M; Uchida S; Watanuki T; Wakabayashi Y; Otsuki K; Matsubara T; Suetsugi M; Funato H; Watanabe Y
Neurosci Lett; 2008 Jun; 438(2):196-9. PubMed ID: 18455873
[TBL] [Abstract][Full Text] [Related]
17. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum.
Fatemi SH; Stary JM; Earle JA; Araghi-Niknam M; Eagan E
Schizophr Res; 2005 Jan; 72(2-3):109-22. PubMed ID: 15560956
[TBL] [Abstract][Full Text] [Related]
18. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.
Perlman WR; Webster MJ; Kleinman JE; Weickert CS
Biol Psychiatry; 2004 Dec; 56(11):844-52. PubMed ID: 15576061
[TBL] [Abstract][Full Text] [Related]
19. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
Zavitsanou K; Katsifis A; Yu Y; Huang XF
Brain Res Bull; 2005 May; 65(5):397-403. PubMed ID: 15833594
[TBL] [Abstract][Full Text] [Related]
20. Microvascular changes in late-life schizophrenia and mood disorders: stereological assessment of capillary diameters in anterior cingulate cortex.
Sinka L; Kovari E; Santos M; Herrmann FR; Gold G; Hof PR; Bouras C; Giannakopoulos P
Neuropathol Appl Neurobiol; 2012 Dec; 38(7):696-709. PubMed ID: 22360590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
